Literature DB >> 6084215

Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy.

B H Doft, G Blankenship.   

Abstract

Fifty eyes of patients with proliferative diabetic retinopathy were followed at frequent intervals to determine the rapidity and stability of retinopathy risk factor regression after argon laser panretinal photocoagulation. Retinopathy risk factors regress rapidly after laser photocoagulation. The incidence of eyes at high risk for severe visual loss (eyes with 3 or more retinopathy risk factors) decreased from 100% prior to treatment to 28% three weeks after treatment. The early response to treatment was a good prognostic indicator of longer term results. Seventy-two percent of eyes which improved from a high- to a low-risk category by three weeks continued to remain at low risk at six months. Sixty-four percent of eyes which failed to improve to a low-risk category by three weeks continued to remain at high risk at six months. The early response to laser panretinal ablation may be used to predict longer-term results.

Entities:  

Mesh:

Year:  1984        PMID: 6084215     DOI: 10.1016/s0161-6420(84)34123-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.

Authors:  L C Olmos; M S Sayed; A L Moraczewski; S J Gedde; P J Rosenfeld; W Shi; W J Feuer; R K Lee
Journal:  Eye (Lond)       Date:  2015-12-18       Impact factor: 3.775

2.  Indirect photocoagulation of subfoveal choroidal neovascularization in age-related macular degeneration.

Authors:  L V Angioletti; P J Colquhoun; A D Kulik; E H Malpica
Journal:  Bull N Y Acad Med       Date:  1991 Jul-Aug

Review 3.  Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors:  Arathi Simha; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-10-02

4.  Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.

Authors:  G W Aylward; R V Pearson; J D Jagger; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

5.  Characterisation of the neovascularisation process in diabetic retinopathy by means of fractal geometry: diagnostic implications.

Authors:  A Daxer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-12       Impact factor: 3.117

6.  Red krypton and blue-green argon laser diabetic panretinal photocoagulation.

Authors:  G W Blankenship; E Gerke; J F Batlle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

7.  Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.

Authors:  Grace E Boynton; Maxwell S Stem; Leon Kwark; Gregory R Jackson; Sina Farsiu; Thomas W Gardner
Journal:  Ophthalmology       Date:  2015-01-17       Impact factor: 12.079

8.  Automated detection of proliferative retinopathy in clinical practice.

Authors:  Audrey Karperien; Herbert F Jelinek; Jorge J G Leandro; João V B Soares; Roberto M Cesar; Alan Luckie
Journal:  Clin Ophthalmol       Date:  2008-03

Review 9.  Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.

Authors:  A Ilarde; M Tuck
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

10.  Early vitrectomy for progressive diabetic proliferations covering the macula.

Authors:  R Grewing; U Mester
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.